Excessive hepatic TG accumulation can also lead to the development of insulin resistance, reducing insulin sensitivity and contributing to metabolic disorders such as diabetes, metabolic syndrome, and MASLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.